Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORMETAZEPAM Cause Contraindicated product administered? 5 Reports in FDA Database

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Contraindicated product administered have been filed in association with LORMETAZEPAM. This represents 0.2% of all adverse event reports for LORMETAZEPAM.

5
Reports of Contraindicated product administered with LORMETAZEPAM
0.2%
of all LORMETAZEPAM reports
0
Deaths
3
Hospitalizations

How Dangerous Is Contraindicated product administered From LORMETAZEPAM?

Of the 5 reports, 3 (60.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORMETAZEPAM. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does LORMETAZEPAM Cause?

Drug abuse (488) Coma (426) Toxicity to various agents (315) Somnolence (310) Fall (246) Poisoning deliberate (218) Intentional overdose (187) Drug dependence (181) Overdose (157) Suicide attempt (150)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which LORMETAZEPAM Alternatives Have Lower Contraindicated product administered Risk?

LORMETAZEPAM vs LORNOXICAM LORMETAZEPAM vs LOSARTAN LORMETAZEPAM vs LOSARTAN\LOSARTAN LORMETAZEPAM vs LOTEPREDNOL ETABONATE LORMETAZEPAM vs LOTEPREDNOL ETABONATE\TOBRAMYCIN

Related Pages

LORMETAZEPAM Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered LORMETAZEPAM Demographics